Danish millionaire's biotech company spends DKK 15m in three months
Danish millionaire René Sindlev's US-based biotech company Enochian Biosciences ends another accounting period with a deficit. The coffers were filled earlier this year, but now the company has DKK 88 million (approximately USD 13.5 million) left for the pursuit of a cure for HIV.
There is a wind of change in US-based biotech firm Enochian Biosciences co-founded by the Danish millionaire René Sindlev.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
